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Conclusion  
Today, for a variety of indications in the head region, 
e.g. metastases, meningiomas, vestibular schwannoma, 
or brain tumors, stereotactic high-precision radiation 
therapy can offer the most precise and particularly 
gentle therapy. Through the close interdisciplinary 
network with the surgical as well as the imaging 
disciplines, innovative concepts are implemented into 
personalized medicine in modern radiooncology. In 
further analysis steps, we plan to examine toxicity rates 
and compare them with other RT treatment strategies. 
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Purpose or Objective  
The primary aim of this study was to report on loco-
regional tumor failure (LRF) rates of elderly head and 
neck squamous cell carcinoma (HNSCC) patients treated 
with definitive radiation therapy compared with those of 
young patients, in relation to the original dose 
distribution, referred to as the centroid-based method. 
The second aim was to determine the most important 
prognostic factors for LRF, local tumor failure (LF) and 
regional tumor failure (RF) for the elderly HNSCC 
patients.  
Material and Methods  
Prospectively collected data was retrospective analyzed 
of all consecutive HNSCC patients treated between April 
2007 and December 2014 treated with definitive radiation 
therapy (66-70 Gy) in our department. A total of 662 
patients were included in the study. 165 patients were 70 
years of age and older, including 35 patients (21.2%) with 
LRF. The centroid-based method was performed to 
classify LRF, LF and RF into five types (figure LRF types); 
A (central therapeutic dose), B (peripheral therapeutic 
dose), C (central elective dose), D (peripheral elective 
dose), and E (extraneous dose). Cox proportional hazards 
model was used to perform univariable and multivariable 





In this study, 147 patients (22.2%) developed LRF. No 
difference between the elderly and young patients was 
observed regarding LRF rate (23.6% versus 24.2%; 
p=0.826) and LF rate (19.8% versus 13.7%; p=0.066). 
However, the 3-year RF rate was significantly lower in 
the elderly compared to the young patients (6.8% versus 
11.4%; p=0.042).  
112 patients (76.2%) were diagnosed with at least one 
LRF classified as tumor failure type A or type B. Nine 
patients (6.1%) with LRF classified as tumor failure type C 
or type D and 15 patients (10.2%) with LRF outside the 
original CTVs. There was no difference in distribution of 
the LRF classifications between the elderly and young 
patients (p=0.482) 
Multivariable Cox regression analysis for LRF type A and B 
showed WHO-PS (p<0.001), primary tumor volume, 
(p=0.002), N-classification (p=0.003), smoking habits 
(p=0.008) treatment technique (p=0.042) as statistical 
significant prognostic factors. Multivariable Cox 
regression analysis for only LF type A and B showed 
primary tumor volume (p<0.001), WHO performance 
score (p=0.036) and smoking habits (p=0.043) as 
statistical significant prognostic factors. Age was not 
found to be statistically significant in both multivariable 
cox regression analysis for LRF and LF (p= 0.385 and 
p=0.391 respectively). No multivariable Cox regression 
analysis for RF could be dose.  
Conclusion  
Patterns of LRF and LF in elderly HNSCC patients do not 
differ from the young patients group. Elderly have 
statistically significant better 3-year cumulative  rates of 
RF compared to young patients. Multivariab le 
prediction model for LRF type A & B and LF type A and B 
for all patients could be made.    
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Purpose or Objective  
The optimal treatment of HNC patients is based on 
proper diagnosis and appropriate clinical staging. 
PET/MRI as a novel hybrid imaging technique which 
enables simultaneous whole body high resolution 
molecular MR and metabolic PET examinations performed 
during one session.  
The purpose of this study was the assessment of the 
impact of [18F] fluorodeoxy-d-glucose (FDG) PET/MR 
hybrid (FDG-PET/MR) hybrid examination on the staging, 
qualification for surgery, radiotherapy (RT), 
chemotherapy or combined treatment of HNC pts and 
target volume delineation during modern VMAT RT 
planning. 
Material and Methods  
Twenty-two pts (F/M: 12/10, mean age: 60 ±  45 13,2 with 
detected clinically, pathologically and in computed 
tomography (CT) squamous cell HNC underwent FDG-
PET/MR using Biograph mMR (Siemens, Germany) system 
before the decision on the treatment. Whole body 
PET/MR scans were obtained 60 min after [18F] FDG 
injection of mean activity of 295  ±  45 MBq. Additionally, 
all pts underwent 18F-FDG PET/MR and gadolinium 
contrast enhanced (CE) MR of the head and neck in the 
